Item
L-Norvaline (L-NORVLN)
The composition of L-Norvaline is 98.5% - 100%.
Acids / Alkalis
Attributes
- Gluten-free
- Ingredient declaration
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Fuller Enterprise USA Inc. | 1735 E. Grevillea Ct. Ontario, CA 91761 |
| Hangzhou FST Pharmaceutical Co., Ltd. | No. 17 Xinsheng Road, Meicheng Town, Jiande City Hangzhou, ZJ 311604 CHN |
| Shandong Aobo Biotech | North Chaoyue Road ETDZ Shandong, Gaotang China CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| CoA Sample | Shandong Aobo Biotech | 2202V03759.pdf | 2/15/2022 | 2/15/2024 |
| Allergens | Shandong Aobo Biotech | Allergens.pdf | 8/17/2022 | 8/16/2024 |
| Lot Code | Fuller Enterprise USA Inc. | Batch Numbering System.pdf | 10/15/2021 | 10/14/2024 |
| BSE - TSE | Fuller Enterprise USA Inc. | BSETSE Free Statement.pdf | 9/21/2020 | 9/21/2023 |
| Ingredient Statement | Fuller Enterprise USA Inc. | Composition Statement.pdf | 10/15/2021 | 10/15/2022 |
| Ingredient Statement | Shandong Aobo Biotech | Composition.pdf | 8/17/2022 | 8/17/2023 |
| Country of Origin | Fuller Enterprise USA Inc. | Country of Origin.pdf | 10/5/2020 | 10/5/2023 |
| Country of Origin | Shandong Aobo Biotech | Country of Origin.pdf | 8/17/2022 | 8/16/2025 |
| HACCP Process Flow Diagram | Fuller Enterprise USA Inc. | Flow Chart.pdf | 1/8/2020 | 1/7/2022 |
| HACCP Process Flow Diagram | Shandong Aobo Biotech | Flow Chart.pdf | 8/23/2022 | 8/22/2024 |
| Gluten | Fuller Enterprise USA Inc. | Gluten Free Statement.pdf | 10/15/2021 | 10/15/2022 |
| HACCP | Fuller Enterprise USA Inc. | HACCP Plan.pdf | 7/14/2021 | 7/13/2024 |
| Halal | Fuller Enterprise USA Inc. | Halal - 20230531.pdf | 5/31/2023 | |
| Halal | Hangzhou FST Pharmaceutical Co., Ltd. | Halal - 20230531.pdf | 5/19/2020 | 5/31/2023 |
| Kosher | Fuller Enterprise USA Inc. | Kosher - 2023.04.30.pdf | 4/30/2022 | 4/30/2023 |
| Kosher | Hangzhou FST Pharmaceutical Co., Ltd. | Kosher - 2024.04.30.pdf | 3/21/2023 | 4/30/2024 |
| Natural | Fuller Enterprise USA Inc. | NaturalSynthetic Statement.pdf | 10/15/2021 | 10/15/2022 |
| GMO | Fuller Enterprise USA Inc. | Non-GMO Statement.pdf | 10/15/2021 | 10/15/2023 |
| Irradiation Status Statement | Fuller Enterprise USA Inc. | Non-IrradiationNon-ETO Statement.pdf | 9/21/2020 | 9/21/2022 |
| Item Questionnaire | Fuller Enterprise USA Inc. | NotApplicable_ItemQuestionnaire.pdf | 2/11/2023 | 2/10/2026 |
| Nutrition | Fuller Enterprise USA Inc. | NotApplicable_Nutrition.pdf | 2/11/2023 | 2/10/2026 |
| Suitability Requirements | Fuller Enterprise USA Inc. | NotApplicable_SuitabilityRequirements.pdf | 2/11/2023 | 2/10/2026 |
| Nutrition | Shandong Aobo Biotech | Nutrition.pdf | 12/9/2022 | 12/8/2025 |
| Pesticide | Fuller Enterprise USA Inc. | Pesticide Statement.pdf | 9/21/2020 | 9/21/2022 |
| Phthalate Esters Letter | Fuller Enterprise USA Inc. | Phthalate Esters Free Statement.pdf | 10/15/2021 | 10/15/2022 |
| Label Sample | Fuller Enterprise USA Inc. | Picture1.jpg | 7/22/2022 | 7/22/2025 |
| California Prop. 65 | Shandong Aobo Biotech | Prop 65 Statement.pdf | 1/21/2022 | 1/21/2024 |
| California Prop. 65 | Fuller Enterprise USA Inc. | Proposition 65 Statement.pdf | 9/21/2020 | 9/21/2022 |
| Residual Statement | Fuller Enterprise USA Inc. | Residual Solvent Statement.pdf | 10/15/2021 | 10/15/2022 |
| Safety Data Sheet (SDS) | Fuller Enterprise USA Inc. | SDS.pdf | 7/9/2021 | 7/8/2024 |
| Product Specification Sheet | Fuller Enterprise USA Inc. | Specification Sheet.pdf | 10/15/2021 | 10/14/2024 |
| Product Specification Sheet | Shandong Aobo Biotech | Specification.pdf | 8/17/2022 | 8/16/2025 |
| Suitability Requirements | Shandong Aobo Biotech | Suitability Requirements.pdf | 12/9/2022 | 12/8/2025 |
| WADA/NSF/NFL Statement | Fuller Enterprise USA Inc. | WADA Statement.pdf | 7/14/2021 | 7/14/2023 |
| CoA Sample | Fuller Enterprise USA Inc. | ZXAS-211201M.pdf | 12/3/2021 | 12/3/2023 |
